These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35617800)

  • 21. Genetic deletion of calcium/calmodulin-dependent protein kinase type II delta does not mitigate adverse myocardial remodeling in volume-overloaded hearts.
    Mohamed BA; Elkenani M; Jakubiczka-Smorag J; Buchholz E; Koszewa S; Lbik D; Schnelle M; Hasenfuss G; Toischer K
    Sci Rep; 2019 Jul; 9(1):9889. PubMed ID: 31285482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRABP1 protects the heart from isoproterenol-induced acute and chronic remodeling.
    Park SW; Persaud SD; Ogokeh S; Meyers TA; Townsend D; Wei LN
    J Endocrinol; 2018 Mar; 236(3):151-165. PubMed ID: 29371236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.
    Liu N; Ruan Y; Denegri M; Bachetti T; Li Y; Colombi B; Napolitano C; Coetzee WA; Priori SG
    J Mol Cell Cardiol; 2011 Jan; 50(1):214-22. PubMed ID: 20937285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy.
    Wu Y; Temple J; Zhang R; Dzhura I; Zhang W; Trimble R; Roden DM; Passier R; Olson EN; Colbran RJ; Anderson ME
    Circulation; 2002 Sep; 106(10):1288-93. PubMed ID: 12208807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combined inhibition of the CaMKIIδ and calcineurin signaling cascade attenuates IGF-IIR-induced cardiac hypertrophy.
    Chen CH; Lin JW; Huang CY; Yeh YL; Shen CY; Badrealam KF; Ho TJ; Padma VV; Kuo WW; Huang CY
    J Cell Physiol; 2020 Apr; 235(4):3539-3547. PubMed ID: 31584202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ca
    Onal B; Gratz D; Hund TJ
    Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1227-H1239. PubMed ID: 28842436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct roles of calmodulin and Ca
    Wang S; Li J; Liu Y; Zhang J; Zheng X; Sun X; Lei S; Kang Z; Chen X; Lei M; Hu H; Zeng X; Hao L
    Biochem Biophys Res Commun; 2020 Jun; 526(4):960-966. PubMed ID: 32303334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained increased CaMKII phosphorylation is involved in the impaired regression of isoproterenol-induced cardiac hypertrophy in rats.
    Li J; Gao Q; Wang S; Kang Z; Li Z; Lei S; Sun X; Zhao M; Chen X; Jiao G; Hu H; Hao L
    J Pharmacol Sci; 2020 Sep; 144(1):30-42. PubMed ID: 32665128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.
    Valverde CA; Mazzocchi G; Di Carlo MN; Ciocci Pardo A; Salas N; Ragone MI; Felice JI; Cely-Ortiz A; Consolini AE; Portiansky E; Mosca S; Kranias EG; Wehrens XHT; Mattiazzi A
    Cardiovasc Res; 2019 Mar; 115(3):556-569. PubMed ID: 30169578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias.
    Gonano LA; Sepúlveda M; Rico Y; Kaetzel M; Valverde CA; Dedman J; Mattiazzi A; Vila Petroff M
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):947-57. PubMed ID: 22009705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The novel CaMKII inhibitor GS-680 reduces diastolic SR Ca leak and prevents CaMKII-dependent pro-arrhythmic activity.
    Lebek S; Plößl A; Baier M; Mustroph J; Tarnowski D; Lücht CM; Schopka S; Flörchinger B; Schmid C; Zausig Y; Pagratis N; Marchand B; Koltun DO; Hung WK; Ahmadyar S; Belardinelli L; Maier LS; Wagner S
    J Mol Cell Cardiol; 2018 May; 118():159-168. PubMed ID: 29614261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium-calmodulin-dependent protein kinase mediates the intracellular signalling pathways of cardiac apoptosis in mice with impaired glucose tolerance.
    Federico M; Portiansky EL; Sommese L; Alvarado FJ; Blanco PG; Zanuzzi CN; Dedman J; Kaetzel M; Wehrens XHT; Mattiazzi A; Palomeque J
    J Physiol; 2017 Jun; 595(12):4089-4108. PubMed ID: 28105734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo.
    Yang Y; Zhu WZ; Joiner ML; Zhang R; Oddis CV; Hou Y; Yang J; Price EE; Gleaves L; Eren M; Ni G; Vaughan DE; Xiao RP; Anderson ME
    Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H3065-75. PubMed ID: 16861697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CaMKII in myocardial hypertrophy and heart failure.
    Anderson ME; Brown JH; Bers DM
    J Mol Cell Cardiol; 2011 Oct; 51(4):468-73. PubMed ID: 21276796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small-conductance Ca
    Tenma T; Mitsuyama H; Watanabe M; Kakutani N; Otsuka Y; Mizukami K; Kamada R; Takahashi M; Takada S; Sabe H; Tsutsui H; Yokoshiki H
    Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H262-H272. PubMed ID: 29631373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular arrhythmias, increased cardiac calmodulin kinase II expression, and altered repolarization kinetics in ANP receptor deficient mice.
    Kirchhof P; Fabritz L; Kilić A; Begrow F; Breithardt G; Kuhn M
    J Mol Cell Cardiol; 2004 May; 36(5):691-700. PubMed ID: 15135664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology.
    Fischer TH; Herting J; Tirilomis T; Renner A; Neef S; Toischer K; Ellenberger D; Förster A; Schmitto JD; Gummert J; Schöndube FA; Hasenfuss G; Maier LS; Sossalla S
    Circulation; 2013 Aug; 128(9):970-81. PubMed ID: 23877259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nifedipine inhibits cardiac hypertrophy and left ventricular dysfunction in response to pressure overload.
    Ago T; Yang Y; Zhai P; Sadoshima J
    J Cardiovasc Transl Res; 2010 Aug; 3(4):304-13. PubMed ID: 20559781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caveolae-specific activation loop between CaMKII and L-type Ca
    Tonegawa K; Otsuka W; Kumagai S; Matsunami S; Hayamizu N; Tanaka S; Moriwaki K; Obana M; Maeda M; Asahi M; Kiyonari H; Fujio Y; Nakayama H
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H501-H514. PubMed ID: 28039202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac specific PRMT1 ablation causes heart failure through CaMKII dysregulation.
    Pyun JH; Kim HJ; Jeong MH; Ahn BY; Vuong TA; Lee DI; Choi S; Koo SH; Cho H; Kang JS
    Nat Commun; 2018 Nov; 9(1):5107. PubMed ID: 30504773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.